Company Filing History:
Years Active: 2007
Title: Innovator Spotlight: Thomas B. Stanley
Introduction: Thomas B. Stanley, an accomplished inventor based in Durham, NC, is known for his significant contributions to the field of biochemistry and pharmacology. With a single patent to his name, he demonstrates the impact that targeted innovations can have in medical science.
Latest Patents: Stanley's patent, titled "Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same," outlines a sophisticated method for modifying nuclear receptor polypeptides. This invention includes aligning a test nuclear receptor polypeptide sequence with reference polypeptide sequences that possess known X-ray structures. The method aims to create a three-dimensional model to identify characteristic differences, which can then be targeted for mutations to enhance the functionality of the test nuclear receptor.
Career Highlights: Currently, Stanley works at SmithKline Beecham Corporation, a prominent player in the pharmaceutical industry. His role involves not only the development of innovative therapeutic solutions but also contributing to the groundbreaking studies surrounding receptor technologies. His single patent underscores the importance of targeted modifications to enhance biochemical processes.
Collaborations: Throughout his career, Stanley has collaborated with notable colleagues including Christopher J. Apolito and Randy K. Bledsoe. Their teamwork reflects the collaborative spirit that is essential in the research and development landscape, particularly within such a complex scientific field.
Conclusion: Thomas B. Stanley represents the next generation of inventors who leverage advanced methodologies to push the boundaries of biochemistry. His work at SmithKline Beecham Corporation and his innovative patent serve as a reminder of the continued importance of inventive thought in solving critical biological challenges.